Interleukin Antibody
Tepilukimig is a bivalent humanized IgG1κ monoclonal antibody inhibitor targeting TSLP-IL7Rα and TSLP-CRLF2. It prevents TSLP from binding to its cell surface receptors (IL7Rα and CRLF2), thereby completely blocking TSLP-driven inflammatory signaling pathways. Tepilukimig is used in the research of allergic and inflammatory diseases, such as atopic dermatitis and asthma.
Product Specifications
Target
Interleukin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog